Mr Michael J Davies, MD | |
800 S Logan Blvd Ste 3200, Hollidaysburg, PA 16648-3050 | |
(814) 944-2097 | |
(814) 941-2303 |
Full Name | Mr Michael J Davies |
---|---|
Gender | Male |
Speciality | Allergy/immunology |
Experience | 25 Years |
Location | 800 S Logan Blvd Ste 3200, Hollidaysburg, Pennsylvania |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1588651087 | NPI | - | NPPES |
1012399800001 | Medicaid | PA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207K00000X | Allergy & Immunology | MD423645 (Pennsylvania) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Upmc Altoona | Altoona, PA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Central Pennsylvania Asthma And Allergy Care, Llc | 5597851287 | 2 |
News Archive
Scientists have discovered that newborn babies are able to pick up a beat days after birth.
Consumers are five times more likely to identify healthy food when they see colour-coded traffic light nutrition labels than when labels present the information numerically by showing what percentage of the recommended daily nutrient intake each portion provides, new research finds.
Work Out World is proud to announce the grand opening of its newest health club in Cranston, RI! This brand new, state of the art facility will be part of the Blast Fitness network which owns & operates health clubs in 13 states, and members have access to over 70 clubs nationwide.
The U.S. Food and Drug Administration has accepted an Investigational New Drug application by physician-scientists at University of California San Diego School of Medicine to conduct the first U.S. clinical trial of an intravenously administered bacteriophage-based therapy.
› Verified 7 days ago
Entity Name | Central Pennsylvania Asthma And Allergy Care, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1083730857 PECOS PAC ID: 5597851287 Enrollment ID: O20071010000657 |
News Archive
Scientists have discovered that newborn babies are able to pick up a beat days after birth.
Consumers are five times more likely to identify healthy food when they see colour-coded traffic light nutrition labels than when labels present the information numerically by showing what percentage of the recommended daily nutrient intake each portion provides, new research finds.
Work Out World is proud to announce the grand opening of its newest health club in Cranston, RI! This brand new, state of the art facility will be part of the Blast Fitness network which owns & operates health clubs in 13 states, and members have access to over 70 clubs nationwide.
The U.S. Food and Drug Administration has accepted an Investigational New Drug application by physician-scientists at University of California San Diego School of Medicine to conduct the first U.S. clinical trial of an intravenously administered bacteriophage-based therapy.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Mr Michael J Davies, MD 800 S Logan Blvd Ste 3200, Hollidaysburg, PA 16648-3050 Ph: (814) 944-2097 | Mr Michael J Davies, MD 800 S Logan Blvd Ste 3200, Hollidaysburg, PA 16648-3050 Ph: (814) 944-2097 |
News Archive
Scientists have discovered that newborn babies are able to pick up a beat days after birth.
Consumers are five times more likely to identify healthy food when they see colour-coded traffic light nutrition labels than when labels present the information numerically by showing what percentage of the recommended daily nutrient intake each portion provides, new research finds.
Work Out World is proud to announce the grand opening of its newest health club in Cranston, RI! This brand new, state of the art facility will be part of the Blast Fitness network which owns & operates health clubs in 13 states, and members have access to over 70 clubs nationwide.
The U.S. Food and Drug Administration has accepted an Investigational New Drug application by physician-scientists at University of California San Diego School of Medicine to conduct the first U.S. clinical trial of an intravenously administered bacteriophage-based therapy.
› Verified 7 days ago